NCT07335302 CARE-BI:a Pilot Study to Improve Patient Comfort and Reduce Psychological Distress During IA Removal
| NCT ID | NCT07335302 |
| Status | Recruiting |
| Phase | — |
| Sponsor | M.D. Anderson Cancer Center |
| Condition | Psychological Distress |
| Study Type | OBSERVATIONAL |
| Enrollment | 36 participants |
| Start Date | 2025-12-18 |
| Primary Completion | 2026-10-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 36 participants in total. It began in 2025-12-18 with a primary completion date of 2026-10-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this research study is to learn about the rate of posttraumatic stress disorder (PTSD) experienced by women after undergoing gynecologic brachytherapy.
Eligibility Criteria
Inclusion Criteria: * Capable of signing informed consent * Age ≥ 18 years old * Receipt of multiple intracavitary brachytherapy treatments for gynecologic cancer * Capable of completing PRO and patient satisfaction surveys and willing to comply with completion of surveys multiple times throughout and after treatment Exclusion Criteria: * Patients without ability to sign informed consent * Patients unwilling or unable to complete PRO and patient satisfaction surveys at the times required by the study
Contact & Investigator
Ann H Klopp, MD, PHD
PRINCIPAL INVESTIGATOR
M.D. Anderson Cancer Center
Frequently Asked Questions
Who can join the NCT07335302 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Psychological Distress. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07335302 currently recruiting?
Yes, NCT07335302 is actively recruiting participants. Contact the research team at aklopp@mdanderson.org for enrollment information.
Where is the NCT07335302 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT07335302 clinical trial?
NCT07335302 is sponsored by M.D. Anderson Cancer Center. The principal investigator is Ann H Klopp, MD, PHD at M.D. Anderson Cancer Center. The trial plans to enroll 36 participants.